NDC 71858-0010-02 - Tirosint
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71858-0010
- Requested NDC
- 71858-0010-02
- Package NDCs from labels
- 71858-0010-4, 71858-0010-1, 71858-0010-2, 71858-0010-02
- Manufacturer
- IBSA Pharma Inc.
- Effective date
- 2026-03-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Tirosint - IBSA Pharma Inc. | IBSA Pharma Inc. | 2026-03-25 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71858-0010-1 | Tirosint | 1 in 1 CARTON | CAPSULE | 1 | 13 | |
| 71858-0010-1 | Tirosint | 10 in 1 BLISTER PACK | CAPSULE | 10 | 13 | |
| 71858-0010-2 | Tirosint | 3 in 1 CARTON | CAPSULE | 3 | 13 | |
| 71858-0010-2 | Tirosint | 10 in 1 BLISTER PACK | CAPSULE | 10 | 13 | |
| 71858-0010-4 | Tirosint | 10 in 1 BLISTER PACK | CAPSULE | 10 | 13 | |
| 71858-0010-4 | Tirosint | 3 in 1 CARTON | CAPSULE | 3 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71858-0010 | TIROSINT (LEVOTHYROXINE SODIUM) CAPSULE [IBSA PHARMA INC.] | 11 | Current NDC, Legacy NDC, 6 package rows | 20241027_7a7ade79-0165-4e31-b84e-667416c00c7e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71858-0010-4 | EA - Each | 71858-0010 | 8f761cf5-7112-4857-b7b7-8b5c293cc319 | 1 | 2018-12-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Libido Stim Liquescence 3014 | LIBIDO STIM LIQUESCENCE | Professional Complementary Health Formulas | 3d59b77d-817b-4021-a6dd-75d3b4b60866 | 2026-01-08 | Warnings | PDC6A3C0OX |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 3d737f79-7fc9-4221-e063-6394a90ac9aa | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Proctozone-G | GLYCERIN | Rising Pharma Holdings, Inc. | 8a5c8ad5-3619-4971-967d-165270a20bc8 | 2026-01-06 | Warnings | PDC6A3C0OX |
| Proctozone GMax | GLYCERIN | Rising Pharma Holdings, Inc. | a13c2be6-d650-4b53-bddd-d55e92fe10c6 | 2026-01-06 | Warnings | PDC6A3C0OX |
| Good Sense Hemorrhoidal Maximum Strength Pain Relief | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | L. Perrigo Company | 1d6142b6-3746-46f1-99ec-4b19d26f056e | 2026-01-06 | Warnings | PDC6A3C0OX |
| Sting Relief prep Pad | STING RELIEF PREP PAD | SHENZHEN BENLIJU BIO-TECH CO.,LTD | 202c7b77-1a48-52a5-e063-6394a90a2eb2 | 2026-01-05 | Warnings | PDC6A3C0OX |
| Skin Cleaning Care Wipes | SKIN CLEANING CARE WIPES | SHENZHEN BENLIJU BIO-TECH CO.,LTD | 203d7a95-65fe-ca65-e063-6294a90acc6e | 2026-01-05 | Warnings | PDC6A3C0OX |
| CVS Maximum OTC Strength Hemorrhoidal with Aloe | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, WHITE PETROLATUM | CVS PHARMACY,INC | b55c63fb-5dfa-4567-8192-58f403868837 | 2026-01-02 | Warnings | PDC6A3C0OX |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | c968836a-f94c-4d13-e053-2995a90a8df5 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db10e666-6204-56cc-e053-2995a90a9e08 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db5dd9d2-4f96-25d0-e053-2995a90af9dc | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | c9f4923e-5625-1d4f-e053-2a95a90aabc9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db89c58f-9dd0-b6d6-e053-2a95a90ae2e7 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | d9cb3417-e8cb-13f8-e053-2a95a90a294b | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | ca4634a5-d8d7-48a4-e053-2995a90a0cd4 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | dac0af5d-622c-e18c-e053-2995a90a5739 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f317a597-4644-746a-e053-2995a90a807f | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e0503b8c-7eb7-269e-e053-2995a90a1bca | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e08c2af4-c20a-3176-e053-2a95a90a1aa9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e3d949ce-731b-6dfe-e053-2a95a90a0074 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.